Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma
Clinical trial NCT03393936 · TERMINATED
Trial details
- NCT number
- NCT03393936
- Sponsor
- Shanghai PerHum Therapeutics Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2022-06-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.